1887

Abstract

Late onset ataxia reported in three independently derived PrP null lines of mice has been attributed to the overexpression of the doppel protein in the CNS of these mice rather than to the loss of PrP. The central role of PrP in the transmissible spongiform encephalopathies (TSEs), the proximity of the gene which encodes doppel () to the PrP gene () and the structural similarity shared by PrP and doppel have led to the proposition that ataxia which develops during TSE disease could, in part, be due to doppel. In order to address this hypothesis, we have crossed our two inbred lines of PrP null mice, which either express (RCM) or do not express (NPU) the gene in the CNS, with mice expressing two alleles of the PrP gene. We have found that the TSE infection does not influence the level of expression of in the CNS at the terminal stages of disease. Moreover, we have demonstrated that the level of expression of in the CNS has no influence on the incubation period, vacuolar pathology nor amount or distribution of PrP deposition in the brains of the TSE-infected mice. Doppel has therefore no apparent influence on the outcome of TSE disease in transgenic mice, suggesting it is unlikely to be involved in the naturally occurring TSE diseases in other species.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-3-705
2002-03-01
2024-05-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/3/0830705a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-3-705&mimeType=html&fmt=ahah

References

  1. Behrens A., Brandner S., Genoud N., Aguzzi A. 2001; Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel. EMBO Reports 2:347–352
    [Google Scholar]
  2. Brown D. R., Qin K. F., Herms J. W., Madlung A., Manson J., Strome R., Fraser P. E., Kruck T., von Bohlen A., Schulz-Schaeffer W., Giese A., Westaway D., Kretzschmar H. 1997; The cellular prion protein binds copper in vivo. Nature 390:684–687
    [Google Scholar]
  3. Bueler H., Fischer M., Lang Y., Bluethmann H., Lipp H. P., Dearmond S. J., Prusiner S. B., Aguet M., Weissmann C. 1992; Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356:577–582
    [Google Scholar]
  4. Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C. 1993; Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
    [Google Scholar]
  5. Chomczynski P., Sacchi N. 1987; Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry 162:156–159
    [Google Scholar]
  6. Collinge J., Whittington M. A., Sidle K. C. L., Smith C. J., Palmer M. S., Clarke A. R., Jefferys J. G. R. 1994; Prion protein is necessary for normal synaptic function. Nature 370:295–297
    [Google Scholar]
  7. Fraser H., Dickinson A. G. 1967; Distribution of experimentally inducted scrapie lesions in the brain. Nature 216:1310–1311
    [Google Scholar]
  8. Fraser H., Dickinson A. G. 1968; The sequential development of the brain lesions of scrapie in three strains of mice. Journal of Comparative Pathology 78:301–311
    [Google Scholar]
  9. Li A., Sakaguchi S., Shigematsu K., Atarashi R., Roy B. C., Nakaoke R., Arima K., Okimura N., Kopacek J., Katamine S. 2000; Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP-deficient mice ataxic due to Purkinje cell degeneration. American Journal of Pathology 157:1447–1452
    [Google Scholar]
  10. Manson J. C., Clarke A. R., Hooper M. L., Aitchison L., McConnell I., Hope J. 1994a; 129/Ola mice carrying a null mutation in PrP that abolishes messenger-RNA production are developmentally normal. Molecular Neurobiology 8:121–127
    [Google Scholar]
  11. Manson J. C., Clarke A. R., McBride P. A., McConnell I., Hope J. 1994b; PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3:331–340
    [Google Scholar]
  12. Mead S., Beck J., Dickinson A., Fisher E. M. C., Collinge J. 2000; Examination of the human prion protein-like gene Doppel for genetic susceptibility to sporadic and variant Creutzfeldt–Jakob disease. Neuroscience Letters 290:117–120
    [Google Scholar]
  13. Mo H. P., Moore R. C., Cohen F. E., Westaway D., Prusiner S. B., Wright P. E., Dyson H. J. 2001; Two different neurodegenerative diseases caused by proteins with similar structures. Proceedings of the National Academy of Sciences, USA 98:2352–2357
    [Google Scholar]
  14. Moore R. C., Redhead N. J., Selfridge J., Hope J., Manson J. C., Melton D. W. 1995; Double replacement gene targeting for the production of a series of mouse strains with different prion protein gene alterations. Biotechnology 13:999–1004
    [Google Scholar]
  15. Moore R. C., Hope J., McBride P. A., McConnell I., Selfridge J., Melton D. W., Manson J. C. 1998; Mice with gene targetted prion protein alterations show that Prnp, Sinc and Prni are congruent. Nature Genetics 18:118–125
    [Google Scholar]
  16. Moore R. C., Lee I. Y., Silverman G. L., Harrison P. M., Strome R., Heinrich C., Karunaratne A., Pasternak S. H., Chishti M. A., Liang Y., Mastrangelo P., Wang K., Smit A. F. A., Katamine S., Carlson G. A., Cohen F. E., Prusiner S. B., Melton D. W., Tremblay P., Hood L. E., Westaway D. 1999; Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein Doppel. Journal of Molecular Biology 292:797–817
    [Google Scholar]
  17. Nishida N., Tremblay P., Sugimoto T., Shigematsu K., Shirabe S., Petromilli C., Erpel S. P., Nakaoke R., Atarashi R., Houtani T., Torchia M., Sakaguchi S., DeArmond S. J., Prusiner S. B., Katamine S. 1999; A mouse prion protein transgene rescues mice deficient for the prion protein gene from Purkinje cell degeneration and demyelination. Laboratory Investigation 79:689–697
    [Google Scholar]
  18. Peoc’h K., Guerin C., Brandel J. P., Launay J. M., Laplanche J. L. 2000; First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neuroscience Letters 286:144–148
    [Google Scholar]
  19. Rossi D., Cozzio A., Flechsig E., Klein M. A., Rulicke T., Aguzzi A., Weissmann C. 2001; Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO Journal 20:694–702
    [Google Scholar]
  20. Sakaguchi S., Katamine S., Nishida N., Moriuchi R., Shigematsu K., Sugimoto T., Nakatani A., Kataoka Y., Houtani T., Shirabe S., Okada H., Hasegawa S., Miyamoto T., Noda T. 1996; Loss of cerebellar Purkinje cells in aged mice homozygous for a disrupted PrP gene. Nature 380:528–531
    [Google Scholar]
  21. Shmerling D., Hegyi I., Fischer M., Blattler T., Brandner S., Gotz J., Rulicke T., Flechsig E., Cozzio A., von Mering C., Hangartner C., Aguzzi A., Weissmann C. 1998; Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93:203–214
    [Google Scholar]
  22. Silverman G. L., Qin K. F., Moore R. C., Yang Y., Mastrangelo P., Tremblay P., Prusiner S. B., Cohen F. E., Westaway D. 2000; Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein – expression in testis and ectopic production in the brains of Prnp(o/o) mice predisposed to Purkinje cell loss. Journal of Biological Chemistry 275:26834–26841
    [Google Scholar]
  23. Stahl N., Borchelt D. R., Prusiner S. B. 1990; Differential release of cellular and scrapie prion proteins from cellular membranes by phosphatidylinositol-specific phospholipase-C. Biochemistry 29:5405–5412
    [Google Scholar]
  24. Tobler I., Gaus S. E., Deboer T., Achermann P., Fischer M., Rulicke T., Moser M., Oesch B., McBride P. A., Manson J. C. 1996; Altered circadian activity rhythms and sleep in mice devoid of prion protein. Nature 380:639–642
    [Google Scholar]
  25. Weissmann C., Aguzzi A. 1999; PrP’s double causes trouble. Science 286:914–915
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-3-705
Loading
/content/journal/jgv/10.1099/0022-1317-83-3-705
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error